| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |